NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/05/2026
Voltar para busca
Dado oficial do USPTO
CELLKEEP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
08/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10
Data de depósito
08/02/2023
Data de registro
24/09/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/09/2024
Última transação
08/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
GB
Examinador
STEINPFAD, SARAH E
Unidade examinadora
N20
Localização atual
PETITIONS OFFICE
Titulares e representantes
Titulares
CelLBxHealth Europe Ltd
Angle Europe Limited
Representantes
Christina M. Licursi Wolf Greenfield & Sacks, P.C.
Classificação técnica
Classes Nice
Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Scientific diagnostic apparatusequipment and instruments for use in detecting cancerous conditions in the fields of cytologyhistology not for medical useall for laboratory use and general research use; disposable cassettes for providing quantitative cell analysis for scientificlaboratory or general research use; apparatus being research laboratory analyzers for use in testing and analysing blood and blood cells not for medical useall for laboratory usediagnostic or general research use; apparatus being slides for harvesting circulating tumor cells from blood samples for use in testing and analysing blood and blood cells not for medical useall for laboratory usediagnostic or general research use; laboratory equipmentmicroscope slides; parts and fittings for the aforesaid goodsnamely laboratory equipment and supplies namelylaboratory glasswarelaboratory storage tubes and laboratory collection tubes
Classe 10
Medical apparatusequipment and instruments for clinical medical diagnosis of cancer and cardiovascular blood disorders and for non-invasive prenatal testing; medical apparatusequipment and instruments for clinical medical diagnosis in the field of embryology; medical apparatusequipment and instruments for clinical medical diagnosis of pre-disposition to cardiovascular disorders; medical testing apparatusequipment and instrumentsapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testingimmunochemical testing apparatus for medical use; parts and fittings for the aforesaid goodsblood collection bags for medical purposesblood testing apparatus in the nature of blood sampling tubes
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/03/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/11/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/03/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/02/2025
FIMP
FINAL DISPOSITION PROCESSED
27/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/12/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
24/09/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
31/08/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/08/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
14/08/2024
CHPB
POST PUBLICATION AMENDMENT - ENTERED
01/08/2024
APET
ASSIGNED TO PETITION STAFF
29/07/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
12/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/07/2024
PUBO
PUBLISHED FOR OPPOSITION
09/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/12/2023
GNRT
NON-FINAL ACTION E-MAILED
01/12/2023
CNRT
NON-FINAL ACTION WRITTEN
01/12/2023
DOCK
ASSIGNED TO EXAMINER
02/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/09/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/09/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
29/09/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/09/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/09/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/09/2023
RFNT
REFUSAL PROCESSED BY IB
07/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/05/2023
RFRR
REFUSAL PROCESSED BY MPU
15/05/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/03/2023
CNRT
NON-FINAL ACTION WRITTEN
24/03/2023
DOCK
ASSIGNED TO EXAMINER
22/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
21/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELLKEEP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.